Home

PAUL THOMAS

CIK 1166776 · President and CEO · last filed 2026-06-26

PAUL THOMAS is a President and CEO who has filed 75 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing, for AXGN, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$15.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.35M

Companies

11

Total Filings

75

Lifetime Open-Market Net

-$15.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AXGN Director 32,395 $41.15 $1.33M -$633.7K 12 2026-06-26
TELA Director 23,600 $0.67 $15.8K $0 1 2026-06-11
ABIOMED INC (ABMD) Delisted Director 6,357 $381.02 $2.42M -$3.42M 13 2022-11-03
SURGALIGN HOLDINGS, INC. (SRGA) Delisted Director 28,610 $0.18 $5.2K $0 3 2022-08-17
RTI SURGICAL, INC. (RTIX) Delisted Director 0 — — $0 5 2019-03-11
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Director 0 — — $0 6 2016-11-30
Roka BioScience, Inc. (ROKA) Delisted President and CEO 85,494 — — $0 4 2016-11-10
ABIOMED INC (APOL) Delisted Director 22,932 — — -$2.60M 11 2016-08-11
KINETIC CONCEPTS INC (KCI) Delisted President, LifeCell Corp. 0 — — $0 1 2008-08-27
LIFECELL CORP (VITA) Delisted Chairman, President and CEO 0 — — -$8.66M 10 2008-06-04
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Director 38,931 — — $0 1 2007-03-05

Recent Filings

75 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-26 AXGN Grant (A) — $0 EDGAR
2026-06-23 AXGN Exer (M) +18,867 $0 EDGAR
2026-06-11 TELA Grant (A) +23,600 $0 EDGAR
2025-12-10 AXGN Sell (S) −21,399 -$633.7K EDGAR
2025-12-09 AXGN Notice (144) −21,399 -$633.7K EDGAR
2025-06-20 AXGN Grant (A) — $0 EDGAR
2024-09-17 AXGN Grant (A) +2,875 $0 EDGAR
2024-09-04 AXGN Exer (M) +11,904 $0 EDGAR
2024-06-10 AXGN Grant (A) +10,653 $0 EDGAR
2023-09-07 AXGN Grant (A) — $0 EDGAR
Showing 1–10 of 75
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.